High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization
- 2 March 2007
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 46 (6), 543-558
- https://doi.org/10.1002/gcc.20438
Abstract
A BAC‐array platform for comparative genomic hybridization was constructed from a library of 32,433 clones providing complete genome coverage, and evaluated by screening for DNA copy number changes in 10 breast cancer cell lines (BT474, MCF7, HCC1937, SK‐BR‐3, L56Br‐C1, ZR‐75‐1, JIMT1, MDA‐MB‐231, MDA‐MB‐361, and HCC2218) and one cell line derived from fibrocystic disease of the breast (MCF10A). These were also characterized by gene expression analysis and found to represent all five recently described breast cancer subtypes using the “intrinsic gene set” and centroid correlation. Three cell lines, HCC1937 and L56BrC1 derived from BRCA1 mutation carriers and MDA‐MB‐231, were of basal‐like subtype and characterized by a high frequency of low‐level gains and losses of typical pattern, including limited deletions on 5q. Four estrogen receptor positive cell lines were of luminal A subtype and characterized by a different pattern of aberrations and high‐level amplifications, including ERBB2 and other 17q amplicons in BT474 and MDA‐MB‐361. SK‐BR‐3 cells, characterized by a complex genome including ERBB2 amplification, massive high‐level amplifications on 8q and a homozygous deletion of CDH1 at 16q22, had an expression signature closest to luminal B subtype. The effects of gene amplifications were verified by gene expression analysis to distinguish targeted genes from silent amplicon passengers. JIMT1, derived from an ERBB2 amplified trastuzumab resistant tumor, was of the ERBB2 subtype. Homozygous deletions included other known targets such as PTEN (HCC1937) and CDKN2A (MDA‐MB‐231, MCF10A), but also new candidate suppressor genes such as FUSSEL18 (HCC1937) and WDR11 (L56Br‐C1) as well as regions without known genes. The tiling BAC‐arrays constitute a powerful tool for high‐resolution genomic profiling suitable for cancer research and clinical diagnostics.Keywords
This publication has 31 references indexed in Scilit:
- Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumorsInternational Journal of Cancer, 2006
- Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissuesLaboratory Investigation, 2005
- Mapping of a Novel Ocular and Cutaneous Malignant Melanoma Susceptibility Locus to Chromosome 9q21.32JNCI Journal of the National Cancer Institute, 2005
- A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancerNature Genetics, 2005
- Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrationsLeukemia, 2005
- Mutations in a new member of the chromodomain gene family cause CHARGE syndromeNature Genetics, 2004
- Genomic microarrays in human genetic disease and cancerHuman Molecular Genetics, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Cancer genomicsCancer Cell, 2002
- A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cellsOncogene, 2001